Wholesale of pharmaceutical and medical goods
FRESENIUS KABI NORGE AS
Revenue 2024
NOK 1.3bn
Operating profit
NOK 78.5m
Equity
NOK 651.4m
Incorporated
1998
Employees
28
Share capital
NOK 50.7m
Key figures · 2024
Current ratio
1.05
Equity ratio
35.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 6.0% | |
| Net margin (%%) | 5.0% | |
| Return on assets (%%) | 4.3% | |
| Likviditet | ||
| Current ratio | 1.05 | |
| Working capital | 53.3m | |
| Soliditet | ||
| Equity ratio (%%) | 35.5% | |
| Debt-to-equity ratio | 1.81 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.